Records containing: Metastatic Renal Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-20CAIX PET/ CT Guided Radiation Therapy in CcRCC.
-
CLINICAL_TRIALS study record update · 2026-03-25A Phase 2 Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma - SPARCC
-
CLINICAL_TRIALS study record update · 2026-02-27Safety and Efficacy of Lu-177 PSMA Treatment in Metastatic Clear Cell Renal Carcinoma
-
CLINICAL_TRIALS study record update · 2026-01-28Cohort Study of SABR Combined With Targeted Therapy and Anti-PD-1 Versus Targeted Therapy and Anti-PD-1 for Recurrent or Metastatic Renal Cell Carcinoma Patients
-
CLINICAL_TRIALS study record update · 2025-06-27Syöpäpotilaan Ennusteen Parantaminen Muuttamalla syövän mikroympäristöä ja Metaboliaa Liikunnalla ja lääkkeellisesti - Measuring Oncological Value of Exercise and Statin
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-08-16A Pilot Study Evaluating the Tolerability of a Ketogenic Diet With Vitamin Supplementation for Patients Receiving Treatment for Metastatic Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2022-05-16Everolimus Modulation of Anti-tumor T CD4 Immune Responses
-
CLINICAL_TRIALS study record update · 2019-01-08Phase I/II Study of Metastatic Cancer That Expresses NY-ESO-1 Using Lymphodepleting Conditioning Followed by Infusion of Gene Engineered Lymphocytes Cotransduced With Genes Encoding IL-12 and Anti-NY ESO-1 TCR
-
CLINICAL_TRIALS study record update · 2018-10-15Safety and Compliance of Patients Treated With Oral Route Anti Cancer Drugs.
-
CLINICAL_TRIALS study record update · 2018-10-02Perfusion CT as a Predictor for Response to Antiangiogenic Therapy in Patients With Metastasized Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2018-01-16Phase II Study of Oral PRednisone 5 mg Bid Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of Vascular Endothelial Growth Factor Receptor-tyrosine Kinase Inhibitors
-
CLINICAL_TRIALS study record update · 2013-03-27Phase I/II Study of Metastatic Cancer That Expresses MAGE-A3/12 Using Lymphodepleting Conditioning Followed by Infusion of Anti-MAGE-A3/12 TCR-Gene Engineered Lymphocytes
-
CLINICAL_TRIALS study record update · 2012-12-11Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal Cancer